A detailed history of Crestwood Advisors Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 144,398 shares of PFE stock, worth $4.05 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
144,398
Previous 148,371 2.68%
Holding current value
$4.05 Million
Previous $4.27 Million 6.18%
% of portfolio
0.09%
Previous 0.1%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$25.89 - $29.73 $102,860 - $118,117
-3,973 Reduced 2.68%
144,398 $4.01 Million
Q4 2023

Jan 29, 2024

SELL
$26.13 - $33.94 $122,784 - $159,484
-4,699 Reduced 3.07%
148,371 $4.27 Million
Q3 2023

Nov 15, 2023

BUY
$32.09 - $37.51 $3.94 Million - $4.6 Million
122,636 Added 402.96%
153,070 $5.08 Million
Q2 2023

Aug 15, 2023

BUY
$36.12 - $41.79 $37,456 - $43,336
1,037 Added 3.53%
30,434 $1.12 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $57,627 - $75,022
-1,463 Reduced 4.74%
29,397 $1.2 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $47,511 - $62,021
-1,138 Reduced 3.56%
30,860 $1.58 Million
Q3 2022

Oct 26, 2022

BUY
$43.76 - $53.42 $9,977 - $12,179
228 Added 0.72%
31,998 $1.4 Million
Q2 2022

Jul 07, 2022

SELL
$46.53 - $55.17 $89,477 - $106,091
-1,923 Reduced 5.71%
31,770 $1.67 Million
Q1 2022

Apr 12, 2022

BUY
$45.75 - $56.69 $63,318 - $78,458
1,384 Added 4.28%
33,693 $1.74 Million
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $5,041 - $7,472
122 Added 0.38%
32,309 $1.91 Million
Q3 2021

Nov 03, 2021

BUY
$39.25 - $50.42 $60,209 - $77,344
1,534 Added 5.0%
32,187 $1.38 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $141,234 - $159,994
-3,933 Reduced 11.37%
30,653 $1.2 Million
Q1 2021

Apr 21, 2021

BUY
$33.49 - $37.77 $70,329 - $79,317
2,100 Added 6.46%
34,586 $1.25 Million
Q4 2020

Feb 09, 2021

BUY
$33.47 - $42.56 $176,018 - $223,823
5,259 Added 19.32%
32,486 $1.2 Million
Q3 2020

Oct 06, 2020

SELL
$31.75 - $37.25 $15,906 - $18,662
-501 Reduced 1.81%
27,227 $999,000
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $49,005 - $59,450
-1,627 Reduced 5.54%
27,728 $860,000
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $72,089 - $102,999
-2,667 Reduced 8.33%
29,355 $958,000
Q4 2019

Feb 12, 2020

SELL
$32.92 - $37.36 $823 - $934
-25 Reduced 0.08%
32,022 $1.26 Million
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $52,081 - $67,534
1,603 Added 5.27%
32,047 $1.15 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $259,599 - $291,470
7,020 Added 29.97%
30,444 $1.32 Million
Q1 2019

May 09, 2019

SELL
$37.5 - $41.2 $30,562 - $33,578
-815 Reduced 3.36%
23,424 $995,000
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $186,310 - $212,413
4,843 Added 24.97%
24,239 $1.06 Million
Q3 2018

Nov 15, 2018

BUY
$34.47 - $41.81 $27,265 - $33,071
791 Added 4.25%
19,396 $855,000
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $22,129 - $23,592
-671 Reduced 3.48%
18,605 $0
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $76,871 - $89,181
-2,409 Reduced 11.11%
19,276 $684,000
Q4 2017

Jan 11, 2018

BUY
$33.26 - $35.29 $61,131 - $64,863
1,838 Added 9.26%
21,685 $785,000
Q3 2017

Nov 20, 2017

BUY
$31.0 - $34.15 $615,257 - $677,775
19,847
19,847 $709,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Crestwood Advisors Group LLC Portfolio

Follow Crestwood Advisors Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.